Back to Search Start Over

B Cell Lymphoma 6 (BCL6): A Conserved Regulator of Immunity and Beyond.

Authors :
Liongue C
Almohaisen FLJ
Ward AC
Source :
International journal of molecular sciences [Int J Mol Sci] 2024 Oct 11; Vol. 25 (20). Date of Electronic Publication: 2024 Oct 11.
Publication Year :
2024

Abstract

B cell lymphoma 6 (BCL6) is a conserved multi-domain protein that functions principally as a transcriptional repressor. This protein regulates many pivotal aspects of immune cell development and function. BCL6 is critical for germinal center (GC) formation and the development of high-affinity antibodies, with key roles in the generation and function of GC B cells, follicular helper T (Tfh) cells, follicular regulatory T (Tfr) cells, and various immune memory cells. BCL6 also controls macrophage production and function as well as performing a myriad of additional roles outside of the immune system. Many of these regulatory functions are conserved throughout evolution. The BCL6 gene is also important in human oncology, particularly in diffuse large B cell lymphoma (DLBCL) and follicular lymphoma (FL), but also extending to many in other cancers, including a unique role in resistance to a variety of therapies, which collectively make BCL6 inhibitors highly sought-after.

Details

Language :
English
ISSN :
1422-0067
Volume :
25
Issue :
20
Database :
MEDLINE
Journal :
International journal of molecular sciences
Publication Type :
Academic Journal
Accession number :
39456751
Full Text :
https://doi.org/10.3390/ijms252010968